| Serial Number | 76250455 |
| Word Mark | RACE |
| Filing Date | Thursday, May 3, 2001 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Thursday, December 26, 2002 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, October 2, 2001 |
| Goods and Services | Research and development in the field of therapeutics including identification of molecular targets in humans for the development of therapeutics through high-throughput screening and lipid profiling |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, May 15, 2001 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Pilot Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Winston-Salem, NC 27101 |
| Party Name | Pilot Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Winston-Salem, NC 27101 |
| Event Date | Event Description |
| Monday, October 27, 2003 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, October 27, 2003 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, June 9, 2003 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, July 22, 2002 | EXTENSION 1 GRANTED |
| Tuesday, June 25, 2002 | EXTENSION 1 FILED |
| Friday, June 28, 2002 | PAPER RECEIVED |
| Tuesday, December 25, 2001 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, October 2, 2001 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 12, 2001 | NOTICE OF PUBLICATION |
| Tuesday, August 14, 2001 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 8, 2001 | ASSIGNED TO EXAMINER |